For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 10

Based on the information you provided, we found the following studies.

  • A Survey of Cancer Survivors Treatment Preferences for Cancer-Related Fatigue The purpose of our study is to see how cancer patients and survivors would like to learn about acupressure or diet as a treatment for their cancer symptoms like fatigue as well as general information about technology used and their environment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bile duct cancer Bladder cancer Bone cancer Brain cancer Breast cancer Cancerous bone tumor, Osteosarcoma Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Fallopian tube cancer HCC, Liver cancer HNPCC, Lynch Syndrome ( Hereditary NonPolyposis Colorectal Cancer ) Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer PPC, Primary peritoneal cancer Prostate cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions and Healthy volunteers
    • More than 18 years old
  • Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy The purpose of this research study is to study the safety and usefulness of a new lung marker (called the anchor transponder) that will be implanted in your lung near the tumor. The new marker may help your doctor give your radiation treatments. This study is researching all of the following topics: Lung cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects with Advanced Solid Tumors The purpose of this phase 1 research study is to evaluate the safety of an investigational drug, MEDI4736, a drug believed to boost a type of immune cell to assist in identifying and attacking cancer cells to determine the dose and schedule that is safe and tolerable in subjects with solid tumors. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Pancreatic cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Randomized Double-blind, Placebo-controlled, Phase 2 Clinical Trial of Alisertib (MLN8237) in Combination with Paclitaxel Versus Placebo in Combination with Paclitaxel as Second Line Therapy for SCLC Study purpose: measure the length of time that your cancer shrinks or is controlled during and after treatment with paclitaxel in combination with either experimental drug alisertib or placebo; evaluate if the combination of alisertib plus paclitaxel is safe in patients with Small Cell Lung Cancer. This study is researching all of the following topics: Lung cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase II study:BRAF inhibitor dabrafenib as a single agent and in combination with MEK inhibitor trametinib in subjects with BRAF V600E mutation positive metastatic stage IV non-small cell lung cancer The purpose of this study is to test the safety of the drugs GSK2118436 (dabrafenib) and GSK1120212 (trametinib) and how well they work.We want to find out what effects these drugs have on people with non-small cell lung cancer (NSCLC).Subjects will receive dabrafenib and trametinib in combination. This study is researching all of the following topics: Lung cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase I safety study of intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies This study is being done to learn whether treatment with Clostridium novyi-NT spores (NT refers to non-toxin producing) is safe and effective in patients with advanced cancers that can no longer be controlled with standard therapy or cancers for which there is no standard effective treatment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bladder cancer Bone cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer Fallopian tube cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Lymphoma NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Salivary Gland Cancer Sarcoma Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1b/2 Study of OMP-59R5 in Combination with Etoposide and Cisplatin in Subjects with Untreated Extensive Stage Small Cell Lung Cancer The study has two portions.The first will test safety and determine the highest tolerable dose of OMP-59R5 in combination with etoposide and cisplatin. The second will test if OMP-59R5 given with etoposide and cisplatin slows tumor growth, shrinks tumors, or if this combination increases longevity. This study is researching all of the following topics: Lung cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1b, Open-label Study of Oral BGJ398 in Combination with Oral BYL719 in Adult Patients with Select Advanced Solid Tumors This clinical research study is to determine how much of experimental drugs BGJ398 and BYL719 can safely be given in combination to patients. Researchers would like to know how much of these two drugs can be given without causing serious side effects and also how these two drugs affect your body. This study is researching all of the following topics: Brain cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Ovarian cancer Pancreatic cancer Prostate cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • E5508Randomized Phase 3 study of Maintenance therapy w/ Bevacizumab, pemetrexed ora combination of Bevacizumab and pemetrexed following Carboplatin, paclitaxel & Bevacizumab for adv Non-Squamous NSCLC The purpose of this study is to find out the best maintenance therapy for patients with advanced stage non-small cell lung cancer. Maintenance therapy is usually given after 4 cycles of standard chemotherapy to keep the disease under control for a longer duration. This study is researching all of the following topics: Lung cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Randomized Phase II Trial of Individualized Radiotherapy Using During-Treatment FDG-PEG/CT and Modern Technology in Locally Advanced Non-Small Cell Lung Cancer The purpose is to find out if more intense (higher dose) radiation treatment based on the FDG-PET/CT imaging improves treatment of your cancer with the same possible damage to healthy lung tissue compared to treatment with standard radiation therapy. This study is researching all of the following topics: Lung cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old